ATE99172T1 - Verwendung von acetyl-l-carnitin zur behandlung von katarakt, sowie pharmazeutische zusammensetzungen fuer eine derartige behandlung. - Google Patents
Verwendung von acetyl-l-carnitin zur behandlung von katarakt, sowie pharmazeutische zusammensetzungen fuer eine derartige behandlung.Info
- Publication number
- ATE99172T1 ATE99172T1 AT89830491T AT89830491T ATE99172T1 AT E99172 T1 ATE99172 T1 AT E99172T1 AT 89830491 T AT89830491 T AT 89830491T AT 89830491 T AT89830491 T AT 89830491T AT E99172 T1 ATE99172 T1 AT E99172T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- carnitine
- acetyl
- cataract
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT8848558A IT1235153B (it) | 1988-11-15 | 1988-11-15 | Uso dell'acetil l-carnitina nel trattamento terapeutico della cataratta e composizioni farmaceutiche utili in tale trattamento |
EP89830491A EP0375628B1 (de) | 1988-11-15 | 1989-11-13 | Verwendung von Acetyl-L-carnitin zur Behandlung von Katarakt, sowie pharmazeutische Zusammensetzungen für eine derartige Behandlung |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE99172T1 true ATE99172T1 (de) | 1994-01-15 |
Family
ID=11267312
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT89830491T ATE99172T1 (de) | 1988-11-15 | 1989-11-13 | Verwendung von acetyl-l-carnitin zur behandlung von katarakt, sowie pharmazeutische zusammensetzungen fuer eine derartige behandlung. |
Country Status (8)
Country | Link |
---|---|
US (1) | US5037851A (de) |
EP (1) | EP0375628B1 (de) |
JP (1) | JPH02180820A (de) |
AT (1) | ATE99172T1 (de) |
DE (1) | DE68911891T2 (de) |
ES (1) | ES2062100T3 (de) |
IT (1) | IT1235153B (de) |
ZA (1) | ZA898667B (de) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5668117A (en) * | 1991-02-22 | 1997-09-16 | Shapiro; Howard K. | Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments |
IT1254314B (it) * | 1992-03-27 | 1995-09-14 | Sigma Tau Ind Farmaceuti | Composizioni farmaceutiche conyenenti l-carnitina e acil- carnitine inassociazione con ace-inibitori per il trattamento di patologie cardiovascolari. |
IT1263004B (it) * | 1992-10-08 | 1996-07-23 | Sigma Tau Ind Farmaceuti | Impiego della l-carnitina e acil l-carnitine nel trattamento a lungo termine di pazienti diabetici non insulino-dipendenti. |
IT1276225B1 (it) * | 1995-10-17 | 1997-10-27 | Sigma Tau Ind Farmaceuti | Composizioni farmaceutiche contenenti l-carnitina e alcanoil l- carnitine in associazione con resveratrolo o suoi derivati utili per |
IT1276253B1 (it) | 1995-12-15 | 1997-10-27 | Sigma Tau Ind Farmaceuti | Composizione farmaceutica contenente l-carnitina o alcanoil l-carnitine per la prevenzione ed il trattamento di stati morbosi |
IT1291113B1 (it) * | 1997-03-20 | 1998-12-29 | Sigma Tau Ind Farmaceuti | Composizione nutritiva terapeutica per soggetti affetti da diabete mellito |
US5863940A (en) | 1997-12-01 | 1999-01-26 | Sigma-Tau Healthscience S.P.A. | Medicament and therapeutical method for treating idiopathic asthenozoospermia |
US6090848A (en) * | 1997-12-01 | 2000-07-18 | Sigma-Tau Healthscience S.P.A. | Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans |
PT951909E (pt) | 1998-03-19 | 2004-04-30 | Sigma Tau Ind Farmaceuti | Composicao combinada que contem uma l-carnitina ou uma alcanoil-l-carnitina um glicosaminoglicano e/ou um seu constituinte |
KR100645980B1 (ko) * | 1998-07-30 | 2006-11-14 | 시그마타우 인두스트리에 파르마슈티케 리우니테 에스.피.에이. | 항암 활성을 갖는 약제의 제조에서 l-카르니틴 및 그의알카노일 유도체의 용도 |
SK287787B6 (sk) * | 2000-12-15 | 2011-09-05 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Použitie L-karnitínu ako stabilizačného činidla proteínov |
US8569367B2 (en) | 2004-11-16 | 2013-10-29 | Allergan, Inc. | Ophthalmic compositions and methods for treating eyes |
CA2611909C (en) * | 2005-07-01 | 2014-01-07 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Composition for treatment of corneal disease |
WO2007006672A1 (en) | 2005-07-08 | 2007-01-18 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Use of a combination comprising l-carnitine or alkanoyl l-carnitine, lipid solubl benzoquinone and omega-3-polyunsaturated fatty acid for the preparation of a dietary supplement or medicament for the treatment of corneal diseases |
US20110015154A1 (en) * | 2009-07-20 | 2011-01-20 | Kellermann Gottfried H | Supporting acetylcholine function |
US20110098265A1 (en) * | 2009-10-28 | 2011-04-28 | Neuroscience, Inc. | Methods for reducing cravings and impulses associated with addictive and compulsive behaviors |
EP2363126A1 (de) | 2010-03-04 | 2011-09-07 | SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. | Zusammensetzung mit L-Carnitin als aktivem Bestandteil in Kombination mit hydroxykynurenine-O-beta-DL-glucoside,zur Verhinderung und/oder Behandlung von Augenkrankheiten, die aufgrund der ultravioletten Strahlung entstanden sind |
US9114120B2 (en) | 2010-11-22 | 2015-08-25 | Sigma-Tau Industrie Farmaceutiche Riunite, S.P.A. | Therapeutical method for the treatment of the Leber optic neuropathy |
US9907826B2 (en) | 2011-12-07 | 2018-03-06 | Allergan, Inc. | Efficient lipid delivery to human tear film using a salt-sensitive emulsion system |
EP2783695A1 (de) | 2013-03-28 | 2014-10-01 | SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. | Physiologische Ergänzung oder Medikament zur ophthalmischen Verwendung mit L-Carnitin oder Alkanoyl-L-Carnitinen in Kombination mit Eledoisin |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1184655B (it) * | 1985-10-14 | 1987-10-28 | Sigma Tau Ind Farmaceuti | Imiego di acetil l-carnitina nel trattamento terapeutico degli stati di shock |
-
1988
- 1988-11-15 IT IT8848558A patent/IT1235153B/it active
-
1989
- 1989-11-13 AT AT89830491T patent/ATE99172T1/de not_active IP Right Cessation
- 1989-11-13 EP EP89830491A patent/EP0375628B1/de not_active Expired - Lifetime
- 1989-11-13 ES ES89830491T patent/ES2062100T3/es not_active Expired - Lifetime
- 1989-11-13 DE DE89830491T patent/DE68911891T2/de not_active Expired - Fee Related
- 1989-11-14 US US07/436,203 patent/US5037851A/en not_active Expired - Lifetime
- 1989-11-14 ZA ZA898667A patent/ZA898667B/xx unknown
- 1989-11-15 JP JP1298729A patent/JPH02180820A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
ZA898667B (en) | 1990-10-31 |
IT1235153B (it) | 1992-06-22 |
IT8848558A0 (it) | 1988-11-15 |
JPH02180820A (ja) | 1990-07-13 |
EP0375628B1 (de) | 1993-12-29 |
DE68911891D1 (de) | 1994-02-10 |
EP0375628A2 (de) | 1990-06-27 |
US5037851A (en) | 1991-08-06 |
ES2062100T3 (es) | 1994-12-16 |
DE68911891T2 (de) | 1994-04-21 |
EP0375628A3 (de) | 1991-08-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE99172T1 (de) | Verwendung von acetyl-l-carnitin zur behandlung von katarakt, sowie pharmazeutische zusammensetzungen fuer eine derartige behandlung. | |
CA2004239A1 (en) | Use of acetyl d-carnitine in the therapeutic treatment of glaucoma, and pharmaceutical compositions useful in such treatment | |
DE69331409D1 (de) | Oral 1alpha-hydroxyprevitamin d | |
ATE204178T1 (de) | Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin | |
BR9306841A (pt) | Composição farmacêutica processo para proporcionar um tratamento anti-histamínico o qual não induz qualquer arritmia cardíaca significativa em um paciente ser humano e uso de uma composição para a mnaufactura de um medicamento para uso em um tratamento anti-histamínico | |
DK0773020T3 (da) | Farmaceutiske præparater indeholdende L-carnitin eller derivater deraf i kombination med resveratrol eller derivater deraf til forebyggelsen og behandlingen af cardiovaskulære lidelser, perifere vaskulære sygdomme og perifer diabetisk neuropati | |
DE58901401D1 (de) | Pharmazeutische zubereitung zur behandlung des diabetes mellitus. | |
ATE108657T1 (de) | Galanthemin enthaltende pharmazeutische formulierung zur behandlung des alkoholismus. | |
DE3876877D1 (de) | Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus. | |
KR970061244A (ko) | 치매 치료용 약학 조성물 | |
KR970025615A (ko) | 암 전이 억제제 | |
IT1244636B (it) | Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento. | |
ES2136167T3 (es) | Composiciones de idebenona para tratar la enfermedad de alzheimer. | |
DE69111974D1 (de) | Verwendung von Lithium zur Behandlung oder Prophylaxe von Molluscum contagiusum. | |
KR910015300A (ko) | 부스피론 : 수면 무호흡증의 치료용도 | |
DE3688787D1 (de) | Herstellung eines arzneimittels gegen arthritis und rheumatismus. | |
ATE123416T1 (de) | Oral verabreichbares pharmazeutisches mittel, insbesondere zur eisen- und magnesiumsubstitutionstherapie. | |
NO960347L (no) | Anvendelse av benzydamid ved behandling av patologiske tilstander forårsaket av TNF | |
ATE79750T1 (de) | Pharmazeutische zusammensetzung mit antikrebswirkung und methode fuer die behandlung von krebs. | |
KR890001558A (ko) | 공황(恐慌) 장애를 경감시키는 제피론 및 이의 약학적 허용 산부가염 | |
ATE323481T1 (de) | Verwendung von propionyl-l-carnitin oder dessen pharmakologisch akzeptabler salze zur herstellung eines medikamentes zur behandlung von la peyronie's krankheit | |
DE3786168D1 (de) | Verwendung von para-aminobenzoesaeure zur herstellung eines arzneimittels zur bekaempfung von photoallergien. | |
SE8304818L (sv) | Medicin med magsarslekande, spasmolytisk och lokalanesteserande verkan | |
ATE73326T1 (de) | Verwendung von l-carnitin zur herstellung eines arzneimittels zur behandlung von toxischen effekten, induziert durch die inhalation von halotan und anderen halogen enthaltenden allgemeinen anaesthetika. | |
TH19526A (th) | วิธีการและสารผสมสำหรับรักษาโรคตับอักเสบชนิดออโตอิมมูน |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |